Published in Invest Ophthalmol Vis Sci on December 01, 2006
Graves' ophthalmopathy. N Engl J Med (2010) 4.24
A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy. J Mol Endocrinol (2011) 1.27
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid (2008) 1.21
Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem (2009) 1.15
Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis (2012) 1.06
Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci (2014) 1.03
Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor. Best Pract Res Clin Endocrinol Metab (2012) 1.03
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab (2012) 1.01
TSH stimulates adipogenesis in mouse embryonic stem cells. J Endocrinol (2008) 0.96
Human longevity is characterised by high thyroid stimulating hormone secretion without altered energy metabolism. Sci Rep (2015) 0.92
Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation. PPAR Res (2008) 0.90
Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor. Cell Mol Life Sci (2010) 0.86
A stimulatory thyrotropin receptor antibody (M22) and thyrotropin increase interleukin-6 expression and secretion in Graves' orbital preadipocyte fibroblasts. Thyroid (2010) 0.85
Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis. J Endocrinol (2009) 0.85
Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy. Thyroid (2013) 0.82
Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy. Curr Opin Endocrinol Diabetes Obes (2008) 0.81
Thyrotropin and obesity: increased adipose triglyceride content through glycerol-3-phosphate acyltransferase 3. Sci Rep (2015) 0.79
A modified ELISA accurately measures secretion of high molecular weight hyaluronan (HA) by Graves' disease orbital cells. Endocrinology (2013) 0.79
Platelet-derived growth factor: a key factor in the pathogenesis of graves' ophthalmopathy and potential target for treatment. Eur Thyroid J (2014) 0.76
Inhibiting thyrotropin/insulin-like growth factor 1 receptor crosstalk to treat Graves' ophthalmopathy: studies in orbital fibroblasts In Vitro. Br J Pharmacol (2016) 0.75
The Role of Thyrotropin Receptor Activation in Adipogenesis and Modulation of Fat Phenotype. Front Endocrinol (Lausanne) (2017) 0.75
Regulation of Wnt signaling during adipogenesis. J Biol Chem (2002) 3.94
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology (2003) 3.04
Human monoclonal thyroid stimulating autoantibody. Lancet (2003) 2.15
Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue. Lancet (1993) 2.13
CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol (2000) 1.89
Regulated production of a peroxisome proliferator-activated receptor-gamma ligand during an early phase of adipocyte differentiation in 3T3-L1 adipocytes. J Biol Chem (2004) 1.75
Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab (1999) 1.59
A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism. J Clin Endocrinol Metab (1996) 1.54
Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. J Mol Endocrinol (2003) 1.33
Thiazolidinedione exposure increases the expression of uncoupling protein 1 in cultured human preadipocytes. Diabetes (1998) 1.25
The thyrotropin receptor in thyroid diseases. N Engl J Med (1997) 1.24
A monoclonal thyroid-stimulating antibody. J Clin Invest (2002) 1.22
Cyclic AMP-mediated control of lipogenic enzyme synthesis during adipose differentiation of 3T3 cells. Cell (1981) 1.21
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J Clin Endocrinol Metab (2003) 1.11
Adipogenesis in thyroid eye disease. Invest Ophthalmol Vis Sci (2000) 1.09
Thyroid-stimulating monoclonal antibodies. Thyroid (2002) 1.07
Thyrotropin receptor transcripts in human adipose tissue. J Clin Endocrinol Metab (1997) 1.07
The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole. J Clin Endocrinol Metab (1994) 1.06
Thyroid-stimulating hormone (TSH)-directed induction of the CREM gene in the thyroid gland participates in the long-term desensitization of the TSH receptor. Proc Natl Acad Sci U S A (1995) 1.04
Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab (1997) 1.01
Culture of human adipose tissue explants leads to profound alteration of adipocyte gene expression. Horm Metab Res (2003) 0.99
Generation of a mouse monoclonal TSH receptor antibody with stimulating activity. Biochem Biophys Res Commun (2002) 0.98
Biological activity of activating thyroid-stimulating hormone receptor mutants depends on the cellular context. Endocrinology (2003) 0.89
Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease. Clin Exp Immunol (2002) 0.88
Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor. Biochem Biophys Res Commun (1996) 0.87
The 3',5'-cyclic adenosine monophosphate response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas. Endocrinology (2000) 0.86
Biological activity of activating thyrotrophin receptor mutants: modulation by iodide. J Mol Endocrinol (2005) 0.85
Effect of activating and inactivating mutations of Gs- and Gi2-alpha protein subunits on growth and differentiation of 3T3-L1 preadipocytes. J Cell Biochem (1997) 0.79
A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology (2003) 3.04
Metformin reduces arterial stiffness and improves endothelial function in young women with polycystic ovary syndrome: a randomized, placebo-controlled, crossover trial. J Clin Endocrinol Metab (2009) 1.18
Thyrotropin receptor activation increases hyaluronan production in preadipocyte fibroblasts: contributory role in hyaluronan accumulation in thyroid dysfunction. J Biol Chem (2009) 1.15
Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use? J Clin Endocrinol Metab (2003) 1.11
Brown fat and obesity: the next big thing? Clin Endocrinol (Oxf) (2011) 1.10
Evidence for a role of the amyloid precursor protein in thyroid carcinogenesis. J Endocrinol (2008) 1.03
Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab (2012) 1.00
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy. Endocrinology (2004) 0.96
FOXO3a: a novel player in thyroid carcinogenesis? Endocr Relat Cancer (2008) 0.92
Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab (2002) 0.89
TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency. J Clin Endocrinol Metab (2008) 0.88
Forkhead box-O transcription factor: critical conductors of cancer's fate. Endocr Relat Cancer (2008) 0.88
Impaired enteral levothyroxine absorption in hypothyroidism refractory to oral therapy after thyroid ablation for papillary thyroid cancer: case report and kinetic studies. Thyroid (2006) 0.87
Proteomic profiling of cold thyroid nodules. Endocrinology (2006) 0.86
Altered tear composition in smokers and patients with graves ophthalmopathy. Arch Ophthalmol (2006) 0.86
Gsalpha signalling suppresses PPARgamma2 generation and inhibits 3T3L1 adipogenesis. J Endocrinol (2009) 0.85
FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide. J Clin Endocrinol Metab (2011) 0.84
Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy. J Clin Endocrinol Metab (2011) 0.84
Proteomics in thyroid tumor research. J Clin Endocrinol Metab (2009) 0.84
Effects of dehydroepiandrosterone replacement on vascular function in primary and secondary adrenal insufficiency: a randomized crossover trial. J Clin Endocrinol Metab (2009) 0.84
Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem (2010) 0.84
FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results. Clin Endocrinol (Oxf) (2012) 0.84
TSH receptor activation and body composition. J Endocrinol (2009) 0.83
Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy. Thyroid (2013) 0.82
A decrease in fasting FGF19 levels is associated with the development of non-alcoholic fatty liver disease in obese adolescents. J Pediatr Endocrinol Metab (2012) 0.82
Modulation of expression of somatostatin receptor subtypes in Graves' ophthalmopathy orbits: relevance to novel analogs. Am J Physiol Endocrinol Metab (2007) 0.82
The association of FGF23 levels in obese adolescents with insulin sensitivity. J Pediatr Endocrinol Metab (2012) 0.81
Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours. J Mol Endocrinol (2012) 0.81
Metamorphic thyroid autoimmunity. Thyroid (2008) 0.81
Toward the application of proteomics to human thyroid tissue. Thyroid (2006) 0.80
Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma. Am J Pathol (2011) 0.80
Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series. Ann Clin Biochem (2011) 0.79
The second wave of the Controlled Antenatal Thyroid Screening (CATS II) study: the cognitive assessment protocol. BMC Endocr Disord (2014) 0.79
Effect of iodine on early stage thyroid autonomy. Genomics (2010) 0.78
Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid. Int J Biochem Cell Biol (2011) 0.77
Generalized seizures as the first manifestation of multihormonal pituitary hormone deficiency causing normovolemic hyponatremia. Am J Case Rep (2013) 0.77
Metabolic syndrome: is the preadipocyte to blame? Clin Endocrinol (Oxf) (2012) 0.76
Thyroid autoantibodies per se do not impair intracytoplasmic sperm injection outcome in euthyroid healthy women. Eur J Endocrinol (2014) 0.76
The role of FOXO3 in DNA damage response in thyrocytes. Endocr Relat Cancer (2011) 0.76
Re: "An activating mutation of the thyrotropin receptor gene in hereditary non-autoimmune hyperthyroidism" by Yung-Seng Lee et al. J Pediatr Endocrinol Metab 2002; 15: 211-215. J Pediatr Endocrinol Metab (2002) 0.75
John Lazarus. Endocr Pract (2009) 0.75
Early changes in thyroid-stimulating antibody activity following radioiodine therapy. Med Princ Pract (2003) 0.75
Characterisation of DEHAL1 expression in thyroid pathologies. Eur J Endocrinol (2007) 0.75
W546X mutation of the thyrotropin receptor causes subclinical hypothyroidism in various clinical settings. Clin Endocrinol (Oxf) (2007) 0.75